Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

P&U and PRIZM begin ophthalmological collaboration

Nov. 25, 1996

New market introduction for dorzolamide

Nov. 21, 1996

Oculex dexamethasone intraocular delivery system superior to eye drops

Nov. 20, 1996

InSite Vision strengthens position on genetic research into glaucoma

Nov. 1, 1996

Hybridon's VEGF-targeting antisense drugs for retinal neovascularization

Nov. 1, 1996

Ciba Vision licenses novel antiglaucoma agent from Ueno

Oct. 25, 1996

Revolutionary treatment for nearsightedness enters pivotal trials

Oct. 18, 1996

Sugen-Allergen collaboration in ophthalmic diseases

Oct. 18, 1996

New use for Uriach's rupatadine

Oct. 11, 1996

Anticataract and NGF production-enhancing compounds

Sep. 27, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...